Answers are grounded in this paper and cite their sources.
Objective. Xenotransplantation is a potential solution for the current organ shortage in organ transplantation. An online international inventory (www. humanxenotransplant.org) has been documenting human xenotransplantation cases since 2006. Previous publications have covered activities over the periods of 1995 to 2010 and 2010 to 2020. Here, we present recent updates that demonstrate major breakthroughs with long-term outcomes. Methods. Information was gathered from different sources, including scientific publications, press releases and news articles from January 2021 to December 2022. Results. During the aforementioned timeframe, four applications of human xenotransplantation involving 6 patients were identified: two trials of heart transplant (involving 3 patients) and two trials of kidney transplant (also involving 3 patients). All cases were performed in the USA and used genetically modified pigs with 1 genetic modification (2 patients) or 10 modifications (4 patients). In total, 5 patients were in a state of brain death during the transplant. Conclusions. Transplantation of life-sustaining solid organs (hearts and kidneys) signifies a major breakthrough in the field of xenotransplantation. The use of organs from genetically modified animals and the broad adoption of the brain-dead deceased donor model also show a paradigm shift in clinical studies of human xenotransplantation. With growing public interest in this field, this information can be used to better inform officials, media, and the public in order to encourage best practice based on internationally harmonized guidelines, following the initiative of the Changsha Communiqués.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: